Neoadjuvant Immunotherapy Improves Outcomes in Treatment of High-risk Liver Cancer
Patients diagnosed with liver cancer (hepatocellular carcinoma; HCC) who received immune checkpoint inhibitors (ICIs) before surgery—including those who would not...
Outcomes
Semaglutide Lowers Risk of Major Kidney Outcomes, Cardiovascular Events, Death in Patients With Diabetes and CKD
In patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), semaglutide reduced the risk of clinically important kidney...
Earlier Treatment for Perinatally Acquired Hepatitis C Leads to Better Outcomes
Starting direct-acting antiviral therapy for children with perinatally acquired hepatitis C at age 3 was linked to a longer life...
Monogram Health and Blue Cross Blue Shield of Arizona Partner to Improve Chronic Kidney Disease Outcomes
Partnership in delivering high quality, affordable care to BCBSAZ Health Choice Pathway HMO D-SNP members managing polychronic kidney disease NASHVILLE,...
